UCFA
VIRX

United Capital Financial Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

United Capital Financial Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42,995
Closed -$860 – 1140
2025
Q1 		$860 Hold
42,995
– – ﹤0.01% 1063
2024
Q4 		$6.88K Hold
42,995
– – ﹤0.01% 1059
2024
Q3 		$9.89K Buy
+42,995
New +$15.8K ﹤0.01% 1053